Literature DB >> 6841648

Prevalence and distribution of ringed sideroblasts in primary myelodysplastic syndromes.

S K Juneja, M Imbert, F Sigaux, H Jouault, C Sultan.   

Abstract

In order to determine the prevalence and percentage distribution of ringed sideroblasts in primary myelodysplastic syndromes, the results of Prussian blue staining were analysed in 133 cases. Ringed sideroblasts ranging from 1 to 86% of cells were found in 76 (57%) cases. The cases of primary myelodysplastic syndrome corresponding to the group entitled "acquired idiopathic sideroblastic anaemia" had between 21 and 86% ringed sideroblasts; these were also found in 40% (26/65) cases corresponding to refractory anaemia with excess of blasts. Seven of the 22 cases having morphological features of refractory anaemia with excess of blasts in transformation had ringed sideroblasts. It would appear that cases of acquired idiopathic sideroblastic anaemia have at least 20% ringed sideroblasts; they also seem to occur frequently in refractory anaemia with excess of blasts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841648      PMCID: PMC498287          DOI: 10.1136/jcp.36.5.566

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  Sideroblasts, siderocytes, and sideroblastic anemia.

Authors:  G E Cartwright; A Deiss
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

2.  SIDEROBLASTIC ANAEMIA, MITOCHONDRIA AND ERYTHROBLASTIC IRON.

Authors:  M C BESSIS; W N JENSEN
Journal:  Br J Haematol       Date:  1965-01       Impact factor: 6.998

Review 3.  Sideroblastic anaemia.

Authors:  S S Bottomley
Journal:  Clin Haematol       Date:  1982-06

4.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

Review 5.  Classification of acute leukemia.

Authors: 
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

Review 6.  [Acquired idiopathic sideroblastic anemia (author's transl)].

Authors:  F Sigaux; M F Richard; M Imbert; C Sultan
Journal:  Pathol Biol (Paris)       Date:  1979-09

Review 7.  Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.

Authors:  D S Cheng; J P Kushner; M M Wintrobe
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

8.  Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes.

Authors:  M Cazzola; G Barosi; C Berzuini; M Dacco; E Orlandi; M Stefanelli; E Ascari
Journal:  Br J Haematol       Date:  1982-01       Impact factor: 6.998

  8 in total
  7 in total

1.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

2.  Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and de novo acute myeloid leukemia.

Authors:  Pedro Martin-Cabrera; Sabine Jeromin; Karolína Perglerovà; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

3.  Is RARS-T a new disease entity or a subtype of RARS or ET?

Authors:  Soo-Mee Bang
Journal:  Korean J Hematol       Date:  2010-06-30

4.  Ring sideroblasts and myelodysplastic syndromes.

Authors:  M Cazzola
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

5.  Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.

Authors:  S K Juneja; M Imbert; H Jouault; J Y Scoazec; F Sigaux; C Sultan
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

Review 6.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

Review 7.  Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?

Authors:  Rafael Bejar
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.